Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for FREE.

Determining whether British American Tobacco at £45.66 is still offering value, or if most of the opportunity is already reflected in the price, starts with understanding how it compares with its fundamentals.

The stock has returned 3.7% over the past 7 days, 4.3% over the last month, 9.0% year to date, 35.9% over 1 year, 125.8% over 3 years and 137.2% over 5 years. This naturally raises questions about how much of that performance aligns with underlying value.

Recent coverage has focused on British American Tobacco’s role in the global tobacco sector, regulatory developments in key markets and the ongoing shift in consumer preferences toward reduced risk products. Together, these themes help explain why the stock continues to attract attention and provide context for assessing whether the price still suits the fundamentals.

On Simply Wall St’s valuation checks, British American Tobacco scores 4 out of 6. Next, you can see how different valuation methods assess the stock, followed by a broader perspective that can help you judge whether those numbers really tell the full story.

British American Tobacco delivered 35.9% returns over the last year. See how this stacks up to the rest of the Tobacco industry.

Approach 1: British American Tobacco Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model looks at the cash British American Tobacco is expected to generate in the future and then discounts those cash flows back to what they might be worth in today’s money.

In this model, the starting point is last twelve month free cash flow of about £5.75b. Analysts and Simply Wall St projections then extend this out using a 2 Stage Free Cash Flow to Equity approach, with forecast free cash flow of £8.43b in 2030. Estimates for 2026 to 2035 combine analyst inputs for the nearer years and extrapolated figures after that, all expressed in £.

When these projected cash flows are discounted back, the model arrives at an estimated intrinsic value of £63.21 per share. Compared to the current share price of £45.66, this suggests the stock is about 27.8% below this DCF estimate, which indicates a meaningful valuation gap on this set of assumptions.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests British American Tobacco is undervalued by 27.8%. Track this in your watchlist or portfolio, or discover 7 more high quality undervalued stocks.

BATS Discounted Cash Flow as at Jun 2026 BATS Discounted Cash Flow as at Jun 2026

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for British American Tobacco.

Approach 2: British American Tobacco Price vs Earnings

For a profitable company, the P/E ratio is often a useful quick check because it tells you how much you are paying for each £1 of current earnings. Investors usually accept a higher P/E when they expect stronger growth or see lower risk, and a lower P/E when they see weaker growth or higher risk.

British American Tobacco currently trades on a P/E of 12.86x. That sits close to the Tobacco industry average P/E of 12.07x and below the broader peer average of 16.62x. Simply Wall St also calculates a “Fair Ratio” for British American Tobacco of 20.78x, which is the P/E level suggested by factors such as its earnings profile, industry, profit margins, market cap and risk characteristics.

This Fair Ratio is more tailored than a simple peer or industry comparison because it adjusts for company specific traits rather than assuming all tobacco stocks deserve the same multiple. Comparing the current P/E of 12.86x with the Fair Ratio of 20.78x indicates that the stock is trading below that model based reference level on this metric.

Result: UNDERVALUED

LSE:BATS P/E Ratio as at Jun 2026 LSE:BATS P/E Ratio as at Jun 2026

Wall Street’s queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab’s valuation page.

Upgrade Your Decision Making: Choose your British American Tobacco Narrative

Earlier it was mentioned that there is an even better way to understand valuation, so this is where Narratives come in, giving you a simple story that links your view on British American Tobacco to specific forecasts for revenue, earnings and margins, and then to a fair value that you can compare with the current £45.66 share price.

A Narrative on Simply Wall St is an easy way for you to spell out your perspective on the company, plug in the numbers that match that view, and see how those assumptions translate into a fair value estimate.

For British American Tobacco, one investor might align with a more cautious Narrative that sits around a fair value of about £39.07, while another might lean toward a more optimistic Narrative that points to fair value closer to £52.00. Both investors can then quickly see whether their fair value suggests the stock looks cheap or expensive relative to the current price.

These Narratives sit in the Community section on Simply Wall St, are used by millions of investors, and are updated as new information such as news, guidance or earnings is reflected in the underlying assumptions, so your story and valuation stay in sync with what is happening with the company.

For British American Tobacco, we will make it really easy for you with previews of two leading British American Tobacco narratives:

🐂 British American Tobacco Bull Case

Fair value in this narrative: £46.21

Gap to fair value compared with the £45.66 share price: about 1.2% below this narrative fair value.

Revenue growth assumption in this narrative: 3.36% a year.

Focuses on growth in reduced risk products, particularly Modern Oral and Heated, alongside broader rollout in emerging markets.

Assumes ongoing cash generation, cost savings programs and digital transformation support earnings resilience and shareholder returns.

Flags regulatory pressure, illicit trade, declining combustibles and ESG driven constraints on capital access as key risks to the story.

🐻 British American Tobacco Bear Case

Fair value in this narrative: £39.07

Gap to fair value compared with the £45.66 share price: about 16.9% above this narrative fair value.

Revenue growth assumption in this narrative: 3.16% a year.

Emphasises tighter regulation, changing consumer attitudes and ESG related selling as ongoing headwinds for both earnings and valuation.

Highlights reliance on combustibles in emerging markets, currency swings and potential pressure on margins as central concerns.

Accepts that newer products, cost savings and cash generation help the investment case, but still sees limited upside relative to the risks.

If those summaries fit how you see British American Tobacco, you can explore the full narratives in more detail, compare the underlying assumptions with your own, and consider which version of the story is closer to your expectations for the stock.

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for British American Tobacco on Simply Wall St. Add the company to your watchlist or portfolio so you’ll be alerted when the story evolves.

Do you think there’s more to the story for British American Tobacco? Head over to our Community to see what others are saying!

LSE:BATS 1-Year Stock Price Chart LSE:BATS 1-Year Stock Price Chart

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include BATS.L.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com